PROTHENA CORP PUBLIC LTD COMPANY

DUBLIN 2, L2 How do I update this listing?

Create Email Alert

Prothena Corp Public LTD Company is based out of Dublin 2. Prothena Corporation plc owns a drug discovery business platform, focused on identifying and translating targets into potential therapies for chronic degenerative and other related disease areas.Whalewisdom has at least 102 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2018-03-29. The notice included securities offered of Equity

Contact Info

prothena corp public ltd company
77 SIR JOHN ROGERSON'S QUAY, BLOCK C
DUBLIN 2 L2    D02 VK60

Business Phone: 011-353-1-236-2500
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2018-03-29 D BIOTECHNOLOGY Equity 49,999,997 49,999,997 0
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
ANDERS O. HARFSTRAND, M.D., PH.D. subscription required
    DIRECTOR
ARTHUR W. HOMAN subscription required
    EXECUTIVE OFFICER
CAROL D. KARP subscription required
    EXECUTIVE OFFICER
CHRISTOPHER S. HENNEY, PH.D., D.SC. subscription required
    DIRECTOR
DENNIS J. SELKOE subscription required
    DIRECTOR
GENE G. KINNEY, PH.D. subscription required
    EXECUTIVE OFFICER DIRECTOR
KARIN L. WALKER subscription required
    EXECUTIVE OFFICER
LARS G. ECKMAN, M.D., PH.D. subscription required
    DIRECTOR
RICHARD T. COLLIER subscription required
    DIRECTOR
SHANE M. COOKE subscription required
    DIRECTOR
TARA NICKERSON, PH.D. subscription required
    EXECUTIVE OFFICER
TRAN B. NGUYEN subscription required
    EXECUTIVE OFFICER
WAGNER M. ZAGO, PH.D. subscription required
    EXECUTIVE OFFICER

Elevate your investments